Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
108M
-
Number of holders
-
279
-
Total 13F shares, excl. options
-
90.4M
-
Shares change
-
+5.42M
-
Total reported value, excl. options
-
$2.49B
-
Value change
-
+$142M
-
Put/Call ratio
-
0.89
-
Number of buys
-
145
-
Number of sells
-
-127
-
Price
-
$27.51
Significant Holders of Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) as of Q1 2024
339 filings reported holding NTLA - Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) has 279 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90.4M shares
of 108M outstanding shares and own 83.82% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (11M shares), BlackRock Inc. (9.11M shares), VANGUARD GROUP INC (9.09M shares), STATE STREET CORP (4.6M shares), Deep Track Capital, LP (4.21M shares), WELLINGTON MANAGEMENT GROUP LLP (4.16M shares), Sumitomo Mitsui Trust Holdings, Inc. (3.4M shares), Nikko Asset Management Americas, Inc. (3.4M shares), MORGAN STANLEY (2.64M shares), and FMR LLC (2.21M shares).
This table shows the top 279 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.